五个
发表于 2025-3-21 19:34:13
书目名称Immunoconjugate Therapy of Hematologic Malignancies影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0462122<br><br> <br><br>书目名称Immunoconjugate Therapy of Hematologic Malignancies影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0462122<br><br> <br><br>书目名称Immunoconjugate Therapy of Hematologic Malignancies网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0462122<br><br> <br><br>书目名称Immunoconjugate Therapy of Hematologic Malignancies网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0462122<br><br> <br><br>书目名称Immunoconjugate Therapy of Hematologic Malignancies被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0462122<br><br> <br><br>书目名称Immunoconjugate Therapy of Hematologic Malignancies被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0462122<br><br> <br><br>书目名称Immunoconjugate Therapy of Hematologic Malignancies年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0462122<br><br> <br><br>书目名称Immunoconjugate Therapy of Hematologic Malignancies年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0462122<br><br> <br><br>书目名称Immunoconjugate Therapy of Hematologic Malignancies读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0462122<br><br> <br><br>书目名称Immunoconjugate Therapy of Hematologic Malignancies读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0462122<br><br> <br><br>
IRS
发表于 2025-3-21 22:46:44
http://reply.papertrans.cn/47/4622/462122/462122_2.png
CURL
发表于 2025-3-22 04:07:42
Treatment of leukemia with radiolabeled monoclonal antibodies,rate that has been achieved by combining chemotherapy with external beam whole-body irradiation and bone marrow transplantation in a small number of eligible patients is based on eradicating virtually all normal and neoplastic hematopoietic cells. Such an approach implicitly acknowledges that select
好忠告人
发表于 2025-3-22 07:17:48
http://reply.papertrans.cn/47/4622/462122/462122_4.png
淘气
发表于 2025-3-22 11:11:33
New approaches to radiolabeling monoclonal antibodies,sults have been obtained in both radioimmunoimaging and radioimmunotherapy trials, several problems related to the biodistribution of radiolabeled monoclonal antibodies have been observed, including the relatively low accumulation of activity in tumor and the excessive accumulation of activity in no
脆弱么
发表于 2025-3-22 14:22:09
http://reply.papertrans.cn/47/4622/462122/462122_6.png
Hyperalgesia
发表于 2025-3-22 20:18:24
Immunotoxins for the therapy of graft versus host disease,es, immunologic disorders, and genetic disorders. Acute graft versus host disease (GVHD), a potential major complication of allogeneic bone marrow transplants, remains a limitation to this approach. In the setting where an HLA-matched sibling is the marrow donor, 30–50% of patients undergoing marrow
Insufficient
发表于 2025-3-23 00:07:17
,Recombinant fusion toxins — A new class of targeted biologic therapeutics, of a toxin, typically diphtheria toxin or Pseudomonas exotoxin [.,.]. These single-chain polypeptides are built upon a product template contained within each toxin molecule. The toxin molecule has three functional domains: (1) the receptor binding domain or targeting ligand recognizes and attaches
反复拉紧
发表于 2025-3-23 02:42:00
Chimeric antibodies for the treatment of hematologic malignancy, the major goals of oncology is to refocus this capacity to mediate tumor specific destruction; to recreate, in effect, the inflammatory response that the tumor has avoided. Such a strategy demands the ability to activate and expand adequate quantities of effector cells (and proteins), to recruit th
cutlery
发表于 2025-3-23 06:31:23
Use of bispecific antibodies in the therapy of tumors,immune disease, graft rejection, and cancer. Although these immunoconjugates have considerable potential, problems associated with their toxicity have slowed their clinical application. Unconjugated MoAb, although not associated with as severe side effects, have generally had little biological activ